These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 32743745)

  • 41. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.
    Falker C; Hartmann A; Guett I; Dohler F; Altmeppen H; Betzel C; Schubert R; Thurm D; Wegwitz F; Joshi P; Verderio C; Krasemann S; Glatzel M
    J Neurochem; 2016 Apr; 137(1):88-100. PubMed ID: 26710111
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapidly progressive Alzheimer's disease features distinct structures of amyloid-β.
    Cohen ML; Kim C; Haldiman T; ElHag M; Mehndiratta P; Pichet T; Lissemore F; Shea M; Cohen Y; Chen W; Blevins J; Appleby BS; Surewicz K; Surewicz WK; Sajatovic M; Tatsuoka C; Zhang S; Mayo P; Butkiewicz M; Haines JL; Lerner AJ; Safar JG
    Brain; 2015 Apr; 138(Pt 4):1009-22. PubMed ID: 25688081
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy.
    Jaunmuktane Z; Mead S; Ellis M; Wadsworth JD; Nicoll AJ; Kenny J; Launchbury F; Linehan J; Richard-Loendt A; Walker AS; Rudge P; Collinge J; Brandner S
    Nature; 2015 Sep; 525(7568):247-50. PubMed ID: 26354483
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
    Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
    Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The prion-like propagation hypothesis in Alzheimer's and Parkinson's disease.
    Duyckaerts C; Clavaguera F; Potier MC
    Curr Opin Neurol; 2019 Apr; 32(2):266-271. PubMed ID: 30724769
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases.
    Morales R; Estrada LD; Diaz-Espinoza R; Morales-Scheihing D; Jara MC; Castilla J; Soto C
    J Neurosci; 2010 Mar; 30(13):4528-35. PubMed ID: 20357103
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alzheimer's disease as oligomeropathy.
    Ono K
    Neurochem Int; 2018 Oct; 119():57-70. PubMed ID: 28821400
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intracerebral seeding of amyloid-β and tau pathology in mice: Factors underlying prion-like spreading and comparisons with α-synuclein.
    McAllister BB; Lacoursiere SG; Sutherland RJ; Mohajerani MH
    Neurosci Biobehav Rev; 2020 May; 112():1-27. PubMed ID: 31996301
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Beta Amyloid Hallmarks: From Intrinsically Disordered Proteins to Alzheimer's Disease.
    Korsak M; Kozyreva T
    Adv Exp Med Biol; 2015; 870():401-21. PubMed ID: 26387111
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alzheimer's disease-associated β-amyloid does not protect against herpes simplex virus 1 infection in the mouse brain.
    Bocharova O; Pandit NP; Molesworth K; Fisher A; Mychko O; Makarava N; Baskakov IV
    J Biol Chem; 2021 Jul; 297(1):100845. PubMed ID: 34052228
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo.
    Vasconcelos B; Stancu IC; Buist A; Bird M; Wang P; Vanoosthuyse A; Van Kolen K; Verheyen A; Kienlen-Campard P; Octave JN; Baatsen P; Moechars D; Dewachter I
    Acta Neuropathol; 2016 Apr; 131(4):549-69. PubMed ID: 26739002
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aβ-ganglioside interactions in the pathogenesis of Alzheimer's disease.
    Matsuzaki K
    Biochim Biophys Acta Biomembr; 2020 Aug; 1862(8):183233. PubMed ID: 32142821
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Amyloid-β: A double agent in Alzheimer's disease?
    Yu H; Wu J
    Biomed Pharmacother; 2021 Jul; 139():111575. PubMed ID: 33845371
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system.
    Tackenberg C; Kulic L; Nitsch RM
    PLoS One; 2020; 15(9):e0239584. PubMed ID: 32966331
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recent advances in the histo-molecular pathology of human prion disease.
    Baiardi S; Rossi M; Capellari S; Parchi P
    Brain Pathol; 2019 Mar; 29(2):278-300. PubMed ID: 30588685
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer's Disease and Other Amyloid Diseases.
    Kreutzer AG; Nowick JS
    Acc Chem Res; 2018 Mar; 51(3):706-718. PubMed ID: 29508987
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diversity in Aβ deposit morphology and secondary proteome insolubility across models of Alzheimer-type amyloidosis.
    Xu G; Fromholt SE; Chakrabarty P; Zhu F; Liu X; Pace MC; Koh J; Golde TE; Levites Y; Lewis J; Borchelt DR
    Acta Neuropathol Commun; 2020 Apr; 8(1):43. PubMed ID: 32252825
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prion infection of mice transgenic for human APPSwe: increased accumulation of cortical formic acid extractable Abeta(1-42) and rapid scrapie disease development.
    Baier M; Apelt J; Riemer C; Gültner S; Schwarz A; Bamme T; Burwinkel M; Schliebs R
    Int J Dev Neurosci; 2008 Nov; 26(7):821-4. PubMed ID: 18662767
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Soluble Aβ aggregates can inhibit prion propagation.
    Sarell CJ; Quarterman E; Yip DC; Terry C; Nicoll AJ; Wadsworth JDF; Farrow MA; Walsh DM; Collinge J
    Open Biol; 2017 Nov; 7(11):. PubMed ID: 29142106
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Point mutations in Aβ induce polymorphic aggregates at liquid/solid interfaces.
    Yates EA; Cucco EM; Legleiter J
    ACS Chem Neurosci; 2011 Jun; 2(6):294-307. PubMed ID: 22778873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.